Cas:52685-51-5 4-iodobut-3-en-2-yl(trimethyl)silane manufacturer & supplier

We serve Chemical Name:4-iodobut-3-en-2-yl(trimethyl)silane CAS:52685-51-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-iodobut-3-en-2-yl(trimethyl)silane

Chemical Name:4-iodobut-3-en-2-yl(trimethyl)silane
CAS.NO:52685-51-5
Synonyms:Silane,(3-iodo-1-methyl-1-propenyl)trimethyl-,(E);((E)-3-IODO-1-METHYLALLYL)-TRIMETHYLSILANE
Molecular Formula:C7H15ISi
Molecular Weight:254.18400
HS Code:2931900090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:188.9ºC at 760 mmHg
Density:1.323g/cm3
Index of Refraction:1.495
PSA:
Exact Mass:253.99900
LogP:3.66340

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Silane,(3-iodo-1-methyl-1-propenyl)trimethyl-,(E) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,((E)-3-IODO-1-METHYLALLYL)-TRIMETHYLSILANE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Silane,(3-iodo-1-methyl-1-propenyl)trimethyl-,(E) Use and application,Silane,(3-iodo-1-methyl-1-propenyl)trimethyl-,(E) technical grade,usp/ep/jp grade.


Related News: In SLE, along with the pivotal TULIP phase III programme, anifrolumab continues to be evaluated in a long-term extension phase III trial.12 A phase II trial of anifrolumab in SLE using subcutaneous delivery has been completed. RNA (hepatitis C virus clone LIVER3-20 gene E2 hypervariable regionHVR1-containing fragment) manufacturers Researchers engineered IgM antibodies and found that in all cases, these antibodies were significantly more potent than standard IgG antibodies in neutralizing the COVID-19 virus. L-Tyrosine, N2-(phenylsulfonyl)-L-ornithyl- suppliers The announcement comes on top of Recipharm’s move into Morocco, which was fueled by local pledges of $500 million. The new facility under construction and due for completion in 2023 will employ 300 and have a capacity of 300 million units annually. 2-Amino-6-(3,5-dimethoxy-phenyl)-3H-pyrimidin-4-one vendor & factory.